Analyst Reco. Rallybio Corporation

Equities

RLYB

US75120L1008

Delayed Nasdaq Other stock markets 16:00:00 2024-05-02 EDT			5-day change	1st Jan Change
1.83 ^USD	-3.68%		+10.91%	-23.43%

04-17	Ralebio Corporation Announces the Presentation of Results from FNAIT Systematic Literature Review and Meta- Analysis At the Academy of Managed Care Pharmacy 2024 Annual Meeting	CI
04-12	Top Premarket Decliners	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Wedbush Lowers Rallybio's PT to $11 From $13 After Private Placement, Adjusts Full-Year 2024 Share Count; Maintains Outperform Rating	04-11	MT
HC Wainwright Cuts Rallybio Price Target to $9 From $12, Maintains Buy Rating	03-13	MT
JMP Securities Adjusts Price Target on Rallybio to $8 From $16, Maintains Market Outperform Rating	02-07	MT
Wedbush Adjusts Rallybio's Price Target to $13 From $14, Keeps Outperform Rating	02-07	MT
Jefferies Downgrades Rallybio to Hold From Buy, Adjusts Price Target to $1.50 From $7	02-07	MT
Evercore ISI Cuts Price Target on Rallybio to $15 From $18, Maintains Outperform Rating	12-21	MT
HC Wainwright Trims Rallybio Price Target to $17 From $18, Maintains Buy Rating	11-10	MT
Wedbush Lowers Rallybio's PT to $14 From $16, Retains Cash Runway Guidance But Increases Discount Rate; Maintains Outperform Rating	11-10	MT
JMP Securities Adjusts Price Target on Rallybio to $16 From $26, Maintains Market Outperform Rating	23-06-26	MT
Wedbush Trims Rallybio Price Target to $16 From $17, Maintains Outperform Rating	23-05-09	MT
HC Wainwright Starts Rallybio at Buy With $18 Price Target	23-04-17	MT
Wedbush Starts Rallybio at Outperform With $17 Price Target, Sees 'Favorable' Risk/Reward Setup	23-04-10	MT
JPMorgan Starts Rallybio at Overweight With $21 Price Target	22-12-09	MT
JMP Securities Increases Rallybio's Price Target to $34 From $29, Keeps Market Outperform Rating	22-08-09	MT
JMP Securities Raises Rallybio's Price Target to $34 From $29, Maintains Market Outperform Rating	22-08-09	MT
JMP Securities Adjusts Rallybio's Price Target to $29 From $32, Keeps Market Outperform Rating	22-03-16	MT
JonesTrading Initiates Rallybio at Buy with $30 Price Target	22-03-07	MT
JMP Securities Initiates Rallybio at Market Outperform With $32 Price Target	22-02-22	MT
RALLYBIO : Evercore ISI Initiates Coverage on Rallybio With Outperform Rating, $40 Price Target	21-08-23	MT
RALLYBIO : Cowen Initiates Coverage on Rallybio With Outperform Rating	21-08-23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Rallybio Corporation

Equities

RLYB

US75120L1008

Analyst Reco.

Filters